HIPEC for Recurrent, Platinum-Sensitive Ovarian Cancer Fails to Improve PFS

Watchdoq December 3, 2024
(MedPage Today) -- Patients with recurrent platinum-sensitive ovarian cancer did just as well with cytoreductive surgery alone as they did with surgery plus intraperitoneal chemotherapy, according to a randomized trial.
Median progression-free...

Read Full Article